LETROZOLE
Manufacturer: Teva Pharmaceuticals USA, Inc.
Score: 141.0
Letrozole is an aromatase inhibitor used in the treatment of breast cancer. It is indicated for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, extended adjuvant treatment of early breast cancer, and first- and second-line treatment of postmenopausal women with hormone receptor-positive or unknown advanced breast cancer. Letrozole works by inhibiting the aromatase enzyme, which is involved in the production of estrogen in the body. The recommended dose of letrozole is 2.5 mg once daily, without regard to meals. Important safety information includes warnings about bone effects, increases in cholesterol, and fatigue and dizziness. Contraindications include pregnancy and known hypersensitivity to the active substance or any of the excipients.
Letrozole can cause fetal harm when administered to a pregnant woman
No dose adjustment is required for patients with renal impairment if creatinine clearance is greater than or equal to 10 mL/min
2.5 mg once daily
Not established
LETROZOLE TABLETS
Yiling Pharmaceutical, Inc.
LETROZOLE TABLETS
Avet Pharmaceuticals Inc.
ANASTROZOLE
Asclemed USA, Inc.
ANASTROZOLE
Zydus Pharmaceuticals USA Inc.
ANASTROZOLE
PD-Rx Pharmaceuticals, Inc.
ANASTROZOLE
Accord Healthcare Inc.
ANASTROZOLE
BluePoint Laboratories
ANASTROZOLE
Chartwell RX, LLC
ANASTROZOLE
American Health Packaging
ANASTROZOLE
Natco Pharma Limited
ANASTROZOLE
NuCare Pharmaceuticals,Inc.
ANASTROZOLE
AvPAK
ANASTROZOLE
PD-Rx Pharmaceuticals, Inc.
ANASTROZOLE
Bryant Ranch Prepack
ANASTROZOLE
A-S Medication Solutions
ANASTROZOLE
Proficient Rx LP
ANASTROZOLE
Bryant Ranch Prepack
ANASTROZOLE
NuCare Pharmaceuticals,Inc.
ANASTROZOLE
ANI Pharmaceuticals, Inc.
ANASTROZOLE
NuCare Pharmaceuticals,Inc.
ANASTROZOLE
REMEDYREPACK INC.
ANASTROZOLE
Major Pharmaceuticals
ANASTROZOLE
Aurobindo Pharma Limited
ANASTROZOLE
A-S Medication Solutions
ANASTROZOLE TABLETS
Yiling Pharmaceutical, Inc.
ANASTROZOLE TABLETS
Proficient Rx LP